Denna sida på svenska
Loading profile information...


Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers
Brenner P, Granqvist M, Königsson J, Al Nimer F, Piehl F, Jokinen J
Psychoneuroendocrinology 2018;89():53-58

Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms
Aeinehband S, Brenner P, Ståhl S, Bhat M, Fidock Md, Khademi M, et al
Brain, behavior, and immunity 2016;51():47-55

Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions
Brenner P, Piehl F
Acta neurologica Scandinavica 2016;134 Suppl 200():47-54

Multiple sclerosis and risk of attempted and completed suicide - a cohort study
Brenner P, Burkill S, Jokinen J, Hillert J, Bahmanyar S, Montgomery S
European journal of neurology 2016;23(8):1329-36

Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls
Brenner P, Mittendorfer-rutz E, Jokinen J, Alexanderson K, Hillert J, Tinghög P
Social psychiatry and psychiatric epidemiology 2016;51(7):1047-54

Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?
Björkenstam C, Tinghög P, Brenner P, Mittendorfer-rutz E, Hillert J, Jokinen J, et al
BMC psychiatry 2015;15():286-

Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study
Brenner P, Alexanderson K, Björkenstam C, Hillert J, Jokinen J, Mittendorfer-rutz E, et al
PloS one 2014;9(8):e104165-